DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 14, 2019, Digirad Corporation (the “Company”) announced that David Noble, the Company’s current Chief Operating Officer, will assume the additional role of Interim Chief Financial Officer of the Company, effective January 15, 2019.
Immediately prior to being appointed Chief Operating Officer of the Company on September 1, 2018, Mr. Noble (age 48) was the Managing Member of Noble Point LLC, a business and financial advisory firm where he, among other things, advised medical practices on operations, growth opportunities and financing from October 2017 to August 2018. Between 2005 and 2017, Mr. Noble served in various capacities at HSBC, including over a decade as Managing Director, Head of Equity Capital Markets (ECM) for the Americas, where he established the Latin American franchise and grew regional revenues to account for a significant portion of their global ECM business. Prior to joining HSBC, Mr. Noble served in various capacities at Lehman Brothers between 1997 and 2005, including as Senior Vice President, Equity Capital Markets. Mr. Noble earned an MBA in Finance from MIT and a BA from Yale University.
There are no arrangements or understandings between Mr. Noble and any other persons to which he was selected as Interim Chief Financial Officer. There are no family relationships between Mr. Noble and any director or executive officer of the Company, and he has no indirect material interest in any transaction required to be disclosed to Item 404(a) of Regulation S-K.
Mr. Noble’s compensation, as disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 10, 2018, remains unchanged.
Item 7.01. Regulation FD Disclosure.
On January 14, 2019, the Company issued a press release announcing Mr. Noble’s appointment to the additional role of Interim Chief Financial Officer of the Company.
Item 9.01. Financial Statements and Exhibits.
DIGIRAD CORP Exhibit
EX-99.1 2 ex991to8k09271004_01142019.htm Exhibit 99.1 News Release For immediate release For more information contact: January 14,…
To view the full exhibit click
About DIGIRAD CORPORATION (NASDAQ:DRAD)
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers.